VEON , reported a 14.6% jump in its annual revenue on Thursday, despite a Russian cyberattack in Ukraine and political unrest in Bangladesh affecting the telecoms group's operations.

to Novo Nordisk (NVO), recorded as a gain in Q4, actual net loss in Q4 came to $(81m). This was down from $(178.4m) in the prior year. Across the full-year, Novavax earned $682m of revenue ...

Working at Novo Nordisk At Novo Nordisk, we dont wait for change. We drive it. Were a dynamic company in an even more dynamic industry, and we know that what got us to where we are today is not ...

Danish company Novo Nordisk's membership in a UK pharmaceutical industry body has been restored after a two-year suspension ...

Novo Nordisk may be reorganizing its early-stage R&D capabilities, but the Danish pharma’s chief scientific officer has insisted that the changes aren’t primarily about laying off staff. | Novo ...

Shares of Novo Nordisk slipped in Monday morning trading after the company announced results of its latest weight-loss drug trial. Novo's results from its Redefine 2 late-stage trial of ...

Novo Nordisk announced that its next-generation weight-loss drug CagriSema helped obese or overweight adult patients with type 2 diabetes lose 15.7% of their weight in a recent trial. That figure ...

Novo Nordisk A/S has a twelve month low of $73.80 and a twelve month high of $148.15. The company has a quick ratio of 0.55, a current ratio of 0.74 and a debt-to-equity ratio of 0.62.

HYDERABAD (Reuters) -Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating ...

Novo Nordisk (NVO) stock was down more than 8% Monday morning after the Danish drugmaker shared new data on its next-generation GLP-1 drug, CagriSema. The drug, a mix of cagrilintide and ...